PMS21 MIXED TREATMENT COMPARISONS- AN EVIDENCE-BASED BUDGET IMPACT MODEL OF RITUXIMAB (MABTHERA) AFTER FAILURE OF ONE OR MORE TNF INHIBITOR THERAPIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Abstract
Authors
R Launois L Riou Frana F Maunoury MC Boissier V Florentin